Ayala Pharmaceuticals, Inc.

CIK: 0001100397

SEC Filings for Ayala Pharmaceuticals, Inc.

SC 13G - Statement of Beneficial Ownership by Certain Investors

Form Type: SC 13G

Filing Date: 2020-01-30

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2020-01-23

View Filing

424B5 - Prospectus [Rule 424(b)(5)]

Form Type: 424B5

Filing Date: 2020-01-21

View Filing

SC 13G/A [Amend] - Statement of Beneficial Ownership by Certain Investors

Form Type: SC 13G/A

Filing Date: 2020-01-21

View Filing

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]

Form Type: 10-K/A

Filing Date: 2020-01-21

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2020-01-16

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2020-01-07

View Filing

SC 13G/A [Amend] - Statement of Beneficial Ownership by Certain Investors

Form Type: SC 13G/A

Filing Date: 2020-01-06

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2019-12-20

View Filing

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form Type: 10-K

Filing Date: 2019-12-20

View Filing